ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Open access · hybridAbstract read
In one paragraph
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
11.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.
- Pooled it
- The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.Neuro-oncology · 2024Pooled it
- Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.The New England journal of medicine · 2023Trial
- MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions.Journal of neuro-oncology · 2026Review
- Multidisciplinary recommendations for routine follow-up of isocitrate dehydrogenase‑mutant glioma in 2026: Adapting clinical practice to the molecular era.Neuro-oncology practice · 2026Review
- The evolution of RTOG and NRG Oncology CNS tumors clinical trials.Journal of neuro-oncology · 2026Review
- Conventional MRI/CT for differentiation of IDH-mutant adult-type diffuse gliomas: revisited with a new imaging feature "scFLAIR-D".Japanese journal of radiology · 2026Article
- Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.Asia-Pacific journal of clinical oncology · 2026Review
- Current and emerging therapies in IDH-mutant glioma.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026Review
- Isocitrate Dehydrogenase-Mutant Astrocytomas: Risk Stratification and Therapeutic Advance.MedComm · 2026Review
- Evaluating work activity and societal burden in patients with grade 2 IDH-mutant glioma.Neuro-oncology practice · 2026Article
- From Classical to Emerging Biomarkers of Brain and Central Nervous System Tumors. An Evidence-Based Review with a Focus on Gliomas.Cellular and molecular neurobiology · 2026Review
- ITPKA suppresses glioma progression and predicts patient prognosis.Frontiers in oncology · 2026Article
- Review
- Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET: A retrospective, bicentric cohort study.Neuro-oncology · 2025Article
- Rapid intraoperative genetic analysis of adult-type diffuse gliomas using a microfluidic real-time polymerase chain reaction device.Neuro-oncology · 2025Article
- Health-related quality of life and cognition in long-term oligodendroglioma survivors: A landmark study.Neuro-oncology · 2025Article
- Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.Neuro-oncology · 2025Observational
- Central Nervous System Tumors in Adolescents and Young Adults.Current neurology and neuroscience reports · 2025Review
- Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study.Radiation oncology (London, England) · 2025Article
Corrections and comments
- Commented on by
Authors and funding
20 authors at 15 institutions in 6 countries.
Andrew B LassmanDivision of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.ORCID 0000-0001-7386-9928
Khê Hoang-XuanAP-HP, Sorbonne Université, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2, Paris, France.
Mei-Yin C PolleyNRG Oncology Statistics and Data Management Center, Philadelphia, PA.ORCID 0000-0003-0106-0323
Alba A BrandesDepartment of Medical Oncology, AUSL/IRCCS Institute of Neurological Sciences, Bologna, Italy.
J Gregory CairncrossCharbonneau Cancer Institute, University of Calgary, Calgary, Canada.
Johan M KrosDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Lynn S AshbyBarrow Neurological Institute, Phoenix, AZ.
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-9949-4722
Luis SouhamiDepartment of Radiation Oncology, McGill University, Montreal, Quebec, Canada.
Winand N M DinjensDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-9298-8380
Nadia N LaackMayo Clinic Accruals for Rochester Methodist Hospital, Rochester, MN.ORCID 0000-0002-4385-6349
Mathilde C M KouwenhovenDepartment of Neurology, Amsterdam Universities Medical Centers, location VUmc, Amsterdam, the Netherlands.ORCID 0000-0001-5252-4365
Karen L FinkBaylor University Medical Center, Houston, TX.
Pim J FrenchDepartment of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.ORCID 0000-0002-0668-9529
David R MacdonaldLondon Regional Cancer Program, Western University, London, Canada (RT).
Denis LacombeEORTC, Brussels, Belgium.
Minhee WonNRG Oncology Statistics and Data Management Center, Philadelphia, PA.
Thierry GorliaEORTC, Brussels, Belgium.
Minesh P MehtaMiami Cancer Institute, Miami, FL.ORCID 0000-0002-4812-5713
Martin J van den BentDepartment of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.ORCID 0000-0001-5710-5127
Erasmus MC Cancer Institute · NLEuropean Organisation for Research and Treatment of Cancer · BENRG Oncology · USAmsterdam University Medical Centers · NLBarrow Neurological Institute · USBaylor University Medical Center · USHouston Methodist · USInstitute of Neurological Sciences · ITLeiden University Medical Center · NLMcGill University · CAMiami Heart Research Institute · USNewYork–Presbyterian Hospital · USSorbonne Université · FRUniversity of Calgary · CAWestern University · CA
Funding
NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8MStatistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI James J. Dignam, GREG YOTHERS · 2014 to 2026
$146.4MNRG Oncology NCORP Research Base-BIQSFPUG1CA189867 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Deborah Watkins Bruner, Lisa A. Kachnic · 2014 to 2026
$140.5MTumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3MNRG Oncology Biospecimen BankU24CA196067 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Tanner J. Freeman, Nilsa Del Carmen Ramirez Milan · 2015 to 2026
$42.6MColumbia University NCI Community Oncology Research ProgramUG1CA189960 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jennifer E. Amengual, Lisa A. Kachnic · 2014 to 2026
$12.7MNCI NIH HHS P30 CA013696NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA196067NCI NIH HHS UG1 CA189867NCI NIH HHS UG1 CA189960
Abstract
PubMed holds no abstract for this paper.
Indexed as
Brain NeoplasmsOligodendrogliomaAntineoplastic Combined Chemotherapy ProtocolsClinical Trials, Phase III as TopicHumansLomustineNeoplasm Recurrence, LocalProcarbazineVincristineLomustineProcarbazineVincristine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.